CLIC4 Antibody

What applications are CLIC4 antibodies most effectively used for?

CLIC4 antibodies are validated for multiple applications with varying effectiveness:

For optimal results in immunohistochemistry applications, antigen retrieval is recommended using TE buffer pH 9.0, though citrate buffer pH 6.0 may serve as an alternative .

What tissue and species reactivity should researchers expect with CLIC4 antibodies?

Most commercially available CLIC4 antibodies demonstrate reactivity across multiple species:

Kidney tissue serves as an excellent positive control for CLIC4 antibody validation due to consistent expression levels across species .

How should researchers interpret CLIC4 localization patterns in different cell types?

CLIC4 demonstrates distinct localization patterns that are critical for proper data interpretation:

• Normal cells: Predominantly cytoplasmic and nuclear localization

• Stressed cells: Translocation to nucleus often observed

• Cancer cells: Often excluded from nucleus in tumor cells but elevated in adjacent stroma

• Specialized structures: Association with mitochondrial inner membrane and cristae demonstrated by immunogold electron microscopy

In malignant tumor samples, diffuse cellular staining is observed in both stromal and tumor cells, while benign tumors may show nuclear-restricted localization .

How can researchers effectively use CLIC4 antibodies to study mitochondrial-associated membrane (MAM) functions?

When investigating CLIC4's role in mitochondrial-associated membranes:

• Subcellular fractionation optimization:

  • Implement differential centrifugation to isolate MAM-enriched fractions

  • Use established MAM markers alongside CLIC4 antibodies (e.g., mitofusin 2, ACSL4, prohibitin)

• Immunofluorescence co-localization approach:

  • Employ dual staining with CLIC4 antibodies and established MAM markers

  • Utilize super-resolution microscopy for precise localization

• Functional validation:

  • Combine antibody-based detection with measurements of Ca²⁺ transfer between ER and mitochondria

  • Correlate CLIC4 expression patterns with mitochondrial physiology measurements

Research demonstrates that CLIC4 localizes to MAMs and plays a critical role in ER-mitochondrial Ca²⁺ homeostasis, affecting mitochondrial physiology and cardioprotection from ischemia-reperfusion injury .

What methodological considerations are important when using CLIC4 antibodies in CLIC4 knockout models?

When working with CLIC4 knockout models:

• Validation of knockout efficiency:

  • Verify complete absence of CLIC4 protein in knockout tissues by Western blot

  • Check for absence of mRNA using PCR even after stimulation (e.g., LPS treatment)

• Control selection:

  • Use wild-type littermates as controls rather than unrelated control animals

  • Consider hemizygous-null mice as additional controls to detect gene dosage effects

• Background strain considerations:

  • Document the genetic background of knockout mice (e.g., C57BL/6J/Tyr C-21)

  • Be aware of potential body weight differences between wild-type and CLIC4-null mice

• Antibody selection:

  • Choose antibodies targeting different epitopes when verifying knockout

  • Consider antibodies targeting N-terminal regions for conditional knockout verification

Research with CLIC4 knockout mice has revealed important roles in inflammatory responses, including diminished LPS responses and compromised host defense against Listeria monocytogenes infection .

How can researchers detect and distinguish between soluble and membrane-associated forms of CLIC4?

CLIC4 exists in both soluble and membrane-integrated forms, requiring specialized approaches:

• Biochemical fractionation:

  • Implement sequential extraction using increasing detergent strengths

  • Compare cytosolic vs. membrane fractions using differential centrifugation

• Sample preparation considerations:

  • Use non-denaturing conditions to preserve membrane-associated forms

  • Consider native PAGE for structural integrity preservation

• Antibody selection criteria:

  • Choose antibodies recognizing conformational epitopes for membrane form detection

  • Consider epitope accessibility differences between forms

• Functional validation:

  • Combine with chloride channel inhibitors (IAA-94, NPPB) to confirm functionality

  • Use stress conditions known to induce membrane translocation

The metamorphic nature of CLIC4 allows it to switch between different structural conformations, with the cytoplasmic soluble form exerting glutaredoxin-like enzymatic functions while the membrane-associated form contributes to chloride channel activity .

How can CLIC4 antibodies be used to study redox regulation and oxidative stress?

CLIC4's redox sensitivity makes it valuable for oxidative stress studies:

• Experimental design considerations:

  • Combine CLIC4 antibody detection with oxidative stress markers (e.g., MitoSOX for superoxide)

  • Compare CLIC4 localization before and after oxidative challenge (e.g., H₂O₂ treatment)

• Functional correlations:

  • Measure oxygen consumption rates alongside CLIC4 detection

  • Assess mitochondrial membrane potential changes and correlate with CLIC4 patterns

• Technical approach:

  • Use fluorescence-activated cell sorting (FACS) to quantify correlations between CLIC4 expression and ROS levels

  • Implement immunogold electron microscopy for precise mitochondrial localization

Research demonstrates that CLIC4-null cancer cells show substantial increases in mitochondrial superoxide generation and altered oxygen consumption patterns, suggesting CLIC4's role in maintaining redox homeostasis .

What controls and validation methods are essential when using CLIC4 antibodies for protein-protein interaction studies?

For robust protein-protein interaction studies:

• Immunoprecipitation optimization:

  • Use epitope-tagged CLIC4 constructs alongside native protein detection

  • Implement appropriate washing stringency to minimize non-specific binding

• Essential controls:

  • Include isotype control antibodies to assess non-specific binding

  • Perform reciprocal co-immunoprecipitation when possible

  • Use CLIC4 knockout or knockdown samples as negative controls

• Validation methods:

  • Confirm interactions using multiple detection methods (e.g., Western blot, mass spectrometry)

  • Verify biological relevance through functional assays

• Technical considerations:

  • Optimize detergent conditions to preserve relevant interactions

  • Consider crosslinking approaches for transient interactions

Proteomic analysis following CLIC4 immunoprecipitation has identified multiple interacting proteins, providing insights into CLIC4's roles in various signaling pathways .

What methodological approach is recommended for studying CLIC4 in disease models, particularly cancer?

When investigating CLIC4 in disease contexts:

• Sample selection and processing:

  • Compare matched normal and diseased tissues from the same patient

  • Distinguish between epithelial and stromal compartments when assessing tumors

• Quantification approaches:

  • Implement digital pathology tools for objective quantification

  • Consider both staining intensity and subcellular localization patterns

• Correlation with disease parameters:

  • Relate CLIC4 expression to patient survival data

  • Compare expression across different disease stages and subtypes

• Functional validation:

  • Combine with siRNA knockdown in relevant cell models

  • Assess changes in proliferation, migration, and other cancer-relevant phenotypes

Research has shown that CLIC4 expression patterns differ between benign and malignant tumors, with CLIC4 potentially serving as a biomarker for epithelial ovarian cancer alongside CA125 .

How should researchers address inconsistent CLIC4 antibody staining patterns across experiments?

Variable CLIC4 staining may result from several factors:

• Biological variables affecting CLIC4 expression:

  • CLIC4 expression can change dynamically in response to stimuli (e.g., POLY I:C stimulation shows transient increases at 24 hours that return to baseline by 48 hours)

  • Nuclear translocation occurs during stress conditions, changing detection patterns

• Technical optimization approaches:

  • Standardize tissue fixation protocols (over-fixation can mask epitopes)

  • Optimize antigen retrieval methods specifically for CLIC4 (TE buffer pH 9.0 recommended)

  • Titrate antibody concentrations to determine optimal signal-to-noise ratio

• Validation strategies:

  • Use multiple antibodies targeting different CLIC4 epitopes

  • Include positive control tissues with known CLIC4 expression (kidney tissue recommended)

  • Implement siRNA knockdown controls to confirm specificity

What are the most effective approaches to targeting CLIC4 beyond antibody-based detection?

Researchers investigating CLIC4 function can implement complementary approaches:

• Small molecule inhibitors:

  • Non-selective inhibitors: IAA-94, NPPB can be used with appropriate controls

  • Structure-based inhibitor discovery: Computational approaches have identified potential selective inhibitors including amphotericin B and rapamycin

• Genetic manipulation tools:

  • siRNA knockdown: 45-50% knockdown efficiency demonstrated with appropriate protocols

  • CRISPR-Cas9 genome editing: For complete knockout in cell models

  • Conditional knockout strategies: Targeting exons 2-4 with loxP sites followed by Cre-mediated deletion

• Protein domains and mutants:

  • Truncation mutants stopping at glutamine-67 (CLIC4Δ Q67) or cysteine-189 (CLIC4Δ C189)

  • Site-directed mutagenesis of key residues like the putative transmembrane domain

• Binding site characterization:

  • GSH-binding region is highly conserved among CLIC family members

  • Allosteric binding sites can be targeted for selective inhibition

How can researchers differentiate between CLIC4 and other CLIC family members in their experiments?

Distinguishing between highly homologous CLIC family proteins requires:

• Antibody selection criteria:

  • Choose antibodies targeting unique regions rather than conserved domains

  • Validate antibody specificity using overexpression systems for each CLIC family member

• Expression pattern analysis:

  • Consider differential expression patterns (e.g., CLIC1 localizes primarily to ER in cardiomyocytes)

  • Examine subcellular distribution differences (CLIC4 shows distinctive mitochondrial association)

• Functional differentiation:

  • CLIC1 null mice show no difference in myocardial infarction after ischemia-reperfusion injury, unlike CLIC4

  • Distribution of CLIC4 but not CLIC1 is altered in heart failure tissue

• Technical approaches:

  • Use isoform-specific primers for RT-PCR validation

  • Implement selective knockdown strategies targeting unique mRNA regions

These methodological distinctions are crucial as the six mammalian CLIC paralogs (CLIC1-CLIC6) share significant structural homology but demonstrate distinct biological functions .

How should researchers interpret CLIC4 expression changes in inflammatory disease contexts?

When studying CLIC4 in inflammation:

• Experimental approach:

  • Monitor CLIC4 expression changes during inflammatory stimulation time courses

  • Compare wild-type and CLIC4-deficient responses to inflammatory stimuli (e.g., LPS, Pam3Cys, poly IC)

• Key parameters to measure:

  • Cytokine/chemokine production (TNF, IL-6, IL-1β, IFNβ, IP-10, CCL5)

  • Activation of inflammatory signaling pathways (e.g., STAT1, IRF3)

• Interpretation framework:

  • CLIC4 generally acts as a positive regulator of inflammatory responses

  • CLIC4-null macrophages demonstrate significantly reduced inflammatory mediator production

  • Systemic inflammation (LPS-induced) shows improved survival in CLIC4-null mice

Importantly, CLIC4 knockdown (45-50% reduction) attenuates STAT1 activation by POLY I:C (30% reduction) and reduces ISG gene expression, but does not affect IRF3 activation, suggesting pathway-specific effects .

What methodological considerations are important when using CLIC4 antibodies as diagnostic or prognostic tools?

For biomarker applications:

• Sample processing standardization:

  • Develop consistent protocols for tissue and serum sample collection

  • Standardize storage conditions to preserve CLIC4 integrity

• Quantification approaches:

  • Implement digital pathology tools for tissue expression analysis

  • Develop high-throughput serum/plasma assays for clinical application

• Validation strategies:

  • Compare CLIC4 with established biomarkers (e.g., CA125 for ovarian cancer)

  • Assess sensitivity and specificity across different disease subtypes and stages

• Prognostic correlation methods:

  • Analyze CLIC4 expression in relation to patient survival data

  • Consider multivariate analysis to account for clinical variables

Research indicates that elevated CLIC4 expression, but not CLIC1 expression, is a negative indicator of patient survival in certain cancers, supporting its potential value as a prognostic biomarker .